Chenyan Li1, Shiqiao Peng1, Xiaomei Zhang1, Xiaochen Xie1, Danyang Wang1, Jinyuan Mao1, Xiaochun Teng1, Zhongyan Shan1, Weiping Teng1. 1. Endocrine Institute and Liaoning Provincial Key Laboratory of Endocrine Diseases (C.L., S.P., X.X., J.M., X.T., Z.S., W.T.), Department of Endocrinology and Metabolism, First Hospital of China Medical University, 110001 Shenyang, China; and Department of Endocrinology (X.Z., D.W.), First Hospital of Dandong, 118000 Dandong, China.
Abstract
CONTEXT: Iodine nutrition is a global event, especially for pregnant women. OBJECTIVE: To develop applicable index of iodine intake for population during pregnancy. DESIGN, SETTING, AND PARTICIPANTS: From 2012 to 2014, pregnant women at less than 8 weeks of gestation (n = 222) and reproductive-age women (n = 827) participated in this study. The pregnant women were evaluated at follow-up visits at 8, 12, 16, 20, 28, and 36 weeks of gestation and 3 and 6 months postpartum. MAIN OUTCOME MEASURES: Twenty-four-hour urine samples were collected at weeks 8 of gestation. Urine iodine (UI) and creatinine (Cr) and serum thyroglobulin were measured in all of the subjects. Circulatory iodine was measured using inductively coupled plasma-mass spectrometry at 8, 20, and 36 weeks of gestation and 6 months postpartum. RESULTS: The median UI concentration decreased from 183.6 to 104.2 μg/L during pregnancy. The serum iodine (SI) changes were similar to the UI to creatinine ratio (UI/Cr). The SI level was lowest at the eighth week of gestation (60.5 μg/L), which rose significantly until 20 weeks (106.5 μg/L) and then began to decline (36 wk, 84.7 μg/L). The 24-hour UI excretion measurement was regarded as the gold standard. The area under the receiver-operating characteristic curve for UI/Cr was 0.92 for iodine deficiency diagnoses and 0.78 for SI. The area for SI was 0.82 for excessive iodine diagnoses and 0.75 for UI/Cr. The areas under these curves were significantly different (P < .001). The areas under the receiver-operating characteristic curve for UI were 0.61 (P = .11) and 0.65 (P = .08) for iodine deficiency and excessive iodine diagnoses, respectively. Additionally, for thyroglobulin, these values were 0.54 (P = .53) and 0.53 (P = .74), respectively. CONCLUSIONS: Iodine intake, as assessed by spot UI concentration in pregnant women, is inaccurate and increases the prevalence of iodine deficiency. The UI/Cr better reflects the 24-hour iodine excretion and circulating iodine levels during pregnancy and the postpartum period.
CONTEXT: Iodine nutrition is a global event, especially for pregnant women. OBJECTIVE: To develop applicable index of iodine intake for population during pregnancy. DESIGN, SETTING, AND PARTICIPANTS: From 2012 to 2014, pregnant women at less than 8 weeks of gestation (n = 222) and reproductive-age women (n = 827) participated in this study. The pregnant women were evaluated at follow-up visits at 8, 12, 16, 20, 28, and 36 weeks of gestation and 3 and 6 months postpartum. MAIN OUTCOME MEASURES: Twenty-four-hour urine samples were collected at weeks 8 of gestation. Urine iodine (UI) and creatinine (Cr) and serum thyroglobulin were measured in all of the subjects. Circulatory iodine was measured using inductively coupled plasma-mass spectrometry at 8, 20, and 36 weeks of gestation and 6 months postpartum. RESULTS: The median UI concentration decreased from 183.6 to 104.2 μg/L during pregnancy. The serum iodine (SI) changes were similar to the UI to creatinine ratio (UI/Cr). The SI level was lowest at the eighth week of gestation (60.5 μg/L), which rose significantly until 20 weeks (106.5 μg/L) and then began to decline (36 wk, 84.7 μg/L). The 24-hour UI excretion measurement was regarded as the gold standard. The area under the receiver-operating characteristic curve for UI/Cr was 0.92 for iodine deficiency diagnoses and 0.78 for SI. The area for SI was 0.82 for excessive iodine diagnoses and 0.75 for UI/Cr. The areas under these curves were significantly different (P < .001). The areas under the receiver-operating characteristic curve for UI were 0.61 (P = .11) and 0.65 (P = .08) for iodine deficiency and excessive iodine diagnoses, respectively. Additionally, for thyroglobulin, these values were 0.54 (P = .53) and 0.53 (P = .74), respectively. CONCLUSIONS:Iodine intake, as assessed by spot UI concentration in pregnant women, is inaccurate and increases the prevalence of iodine deficiency. The UI/Cr better reflects the 24-hour iodine excretion and circulating iodine levels during pregnancy and the postpartum period.
Authors: Mariana Dineva; Margaret P Rayman; Deborah Levie; Mònica Guxens; Robin P Peeters; Jesus Vioque; Llúcia González; Mercedes Espada; Jesús Ibarluzea; Jordi Sunyer; Tim I M Korevaar; Sarah C Bath Journal: Eur J Nutr Date: 2019-02-08 Impact factor: 5.614
Authors: Monika Katko; Andrea Anett Gazso; Ildiko Hircsu; Harjit Pal Bhattoa; Zsuzsanna Molnar; Bela Kovacs; David Andrasi; Janos Aranyosi; Rita Makai; Lajos Veress; Olga Torok; Miklos Bodor; Laszlo Samson; Endre V Nagy Journal: Matern Child Nutr Date: 2017-06-07 Impact factor: 3.092
Authors: Sarah C Bath; Victor J M Pop; Victoria L Furmidge-Owen; Maarten A C Broeren; Margaret P Rayman Journal: Thyroid Date: 2016-11-18 Impact factor: 6.568